uniQure

Richard Porter, Ph.D., Chief Business and Scientific Officer

Oct. 8 | 1:30pm | FLW Ballroom F 

Amsterdam, Netherlands

(NASDAQ: QURE)

Leader in AAV Gene Therapy

www.uniqure.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions